Durham Research Online
You are in:

Engineering eukaryotic protein factories.

Schröder, M. (2008) 'Engineering eukaryotic protein factories.', Biotechnology letters., 30 (2). pp. 187-196.

Abstract

The biopharmaceuticals market is currently outperforming the pharmaceuticals market and is now valued at US$ 48 billion with an average annual growth of 19%. Behind this success is a 100-fold increase in productivities of eukaryotic expression systems. However, the productivity per cell has remained unchanged for more than 10 years. The engineering of the ER-resident protein folding machinery is discussed together with an overview of signal transduction pathways activated by heterologous protein overexpression to increase cell specific productivities.

Item Type:Article
Keywords:Unfolded protein response, Endoplasmic reticulum, Molecular chaperone, Recombinant protein production, Heterologous protein production, Protein folding.
Full text:PDF - Published Version (350Kb)
Status:Peer-reviewed
Publisher Web site:http://dx.doi.org/10.1007/s10529-007-9524-1
Publisher statement:This article is published under a Creative Commons Attribution (CC-BY) license.
Record Created:31 May 2012 12:50
Last Modified:12 Jun 2012 10:32

Social bookmarking: del.icio.usConnoteaBibSonomyCiteULikeFacebookTwitterExport: EndNote, Zotero | BibTex
Usage statisticsLook up in GoogleScholar | Find in a UK Library